Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
about
Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register studyDevelopment and evaluation of a computerised clinical decision support system for switching drugs at the interface between primary and tertiary care.A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.Physicians' perception of generic and electronic prescribing: A descriptive study from JordanComment on: Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe by Johnston et alCommunity pharmacists' attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan.Is there a need for a formulary of clinically interchangeable medicines to guide generic substitution in Saudi Arabia?Effects of hospital generic drug substitution on diabetes therapy.Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006.Evaluating patients' perceptions regarding generic medicines in Jordan.Substitutes of Prescription Medicines - A Review of Concerns Relevant to Doctors and Patients.Impact of brand-name drug worship and expectation psychology on antidepressant efficacyImpact of generic substitution practice on care of diabetic patients.Generic substitution does not seem to affect adherence negatively in elderly polypharmacy patients.Strategic procurement and international collaboration to improve access to medicines.Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
P2860
Q28544265-35A659F4-4672-4ACB-A26E-30A76E799F92Q34491652-339B9D9A-4A9C-4F81-AF4A-F1811D4EA6BBQ34536861-8A8A7EB8-6DC8-4C6C-B984-434B8979D374Q35198487-186651CA-944D-48CF-98A4-61DEB87BEBE9Q35624575-A5274F8F-B611-4609-B511-46C88657A8AFQ35741403-C2C778E0-BFE7-464E-9E47-5ECBFE0E7984Q37134436-F0F0714A-1D48-4751-B009-FF061ABC0B9CQ37554240-E8F8162E-355F-4176-A844-25A1D6E59804Q37556063-E4A753EE-5A39-4696-BC4C-E17823C35AA8Q37703344-FF422866-F98B-4CA4-B2A3-FD847E35A14AQ42029035-FA033A19-870E-43B3-8695-74F9D1FD3F60Q42584470-A661E32A-CD8A-472D-98AE-7DA48D5492BBQ43855810-6295A6BA-0223-45AC-A302-E409A661CD91Q45328877-21A087E0-FC05-46D9-BFF6-DF7AFFA449D5Q47262256-B906F999-EF47-4E82-90B7-67BE9E13510EQ47998668-CEF26C07-332D-4AB3-A0CE-DC0FAEC74216
P2860
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
@en
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
@nl
type
label
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
@en
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
@nl
prefLabel
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
@en
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
@nl
P2093
P2860
P1476
Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.
@en
P2093
Atholl Johnston
David Albert Jones
Enrico Agabiti Rosei
Graham Macgregor
Jens Jordan
José Zamorano
Michael Livingston
Michael Sobanja
Panagiotis Stafylas
P2860
P304
P356
10.1111/J.1365-2125.2011.03987.X
P407
P577
2011-11-01T00:00:00Z